Diabetic ketoacidosis associated with cocaine use

Archives of Internal Medicine

Volumn 158, Issue 16, 1998, Pages 1799-1802

  Warner, Elizabeth A ^a   Greene, Geoffrey S ^a   Buchsbaum, Michael S ^a   Cooper, David S ^a   Robinson, Bruce E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BICARBONATE; CATECHOLAMINE; COCAINE; CORTICOTROPIN; CREATININE; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; KETONE DERIVATIVE; NORADRENALIN; POTASSIUM; SODIUM; TERBUTALINE SULFATE;

ADULT; ANOREXIA; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD CHEMISTRY; BLOOD PH; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; DIABETIC KETOACIDOSIS; FEMALE; HOSPITALS, TEACHING; HOSPITALS, URBAN; HUMANS; MALE; MEDICAL RECORDS; RETROSPECTIVE STUDIES;

EID: 0032517065     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.16.1799     Document Type: Article

References (41)

1. Kitabchi AE, Fisher JN, Murphy MB, Rumbak MJ. Diabetic ketoacidosis and the hyperglycemic hyperosmolar nonketotic state. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. 13th ed. Philadelphia, Pa: Lea & Febiger; 1994:738-770.
2. Schade DS, Eaton RP. The controversy concerning counterregulatory hormone secretion: a hypothesis for the prevention of diabetic ketoacidosis. Diabetes. 1977; 26:596-601.
3. Beigelman PM, Warner NE. Thirty-two fatal cases of severe diabetic ketoacidosis, a case of mucormycosis. Diabetes. 1973;22:847-850.
4. Opie LH, Tansey MJ, Kennelly BM. The heart in diabetes mellitus, part II: acute myocardial infarction and diabetes. S Afr Med J. 1979;56:256-261.
5. Snorgaard O, Eskildsen PC, Vadstrup S, et al. Diabetic ketoacidosis in Denmark: epidemiology, incidence rates, precipitating factors and mortality rates. J Intern Med. 1989;226:223-228.
6. Edelman ER, Stuenkel CA, Rutherford JD, Williams GH. Diabetic ketoacidosis associated with pheochromocytoma. Cleve Clin J Med. 1992;59:423-427.
7. Zonszein J, Baylor P. Diabetic ketoacidosis with alkalemia: a review. West J Med. 1988;149:217-219.
8. Abrahamson MJ. Death from diabetic ketoacidosis after cessation of octreotide in acromegaly. Lancet. 1990;336:318-319.
9. Lefebvre J, Lelièvre G, Dalle-Furnari MA, et al. Glucagonoma with diabetic ketoacidosis: case report. Diabetes Metab. 1982;8:191-195.
10. Greenbaum G, Riley JD. Anaphylaxis-induced diabetic ketoacidosis. Am J Emerg Med. 1994;12:331-333.
11. Tibaldi JM, Lorber DL, Nerenberg A. Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: a case report. Am J Obstet Gynecol. 1990;163:509-510.
12. Chiueh CC, Kopin IJ. Centrally mediated release by cocaine of endogenous epinephrine and norepinepnrine from the sympathoadrenal medullary system of unanesthetized rats. J Pharmacol Exp Ther. 1978;205:148-154.
13. Karch SB. Serum catecholamines in cocaine intoxicated patients with cardiac symptoms. Ann Emerg Med. 1987;16:481.
14. Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhodes E. Acute effects of cocaine on plasma ACTH, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther. 1992;263:505-509.
15. Teoh SK, Sarnyai Z, Mendelson JH, et al. Cocaine effects on pulsatile secretion of ACTH in men. J Pharmacol Exp Ther. 1994;270:1134-1138.
16. Baumann MH, Gendron TM, Becketts KM, et al. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry. 1995; 38:751-755.
17. Heesch CM, Negus BH, Keffer JH, et al. Effects of cocaine on cortisol secretion in humans. Am J Med Sci. 1995;310:61-64.
18. Umpierrez GE, Kelly JP, Navarette JE, Casals MMC, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med. 1997;157:669-675.
19. National Institute of Drug Abuse. National Household Survey on Drug Abuse: Population Estimates, 1993. Washington, DC: US Dept of Health and Human Services: 1994. DHHS publication (ADM) 94-0397.
20. Warner EA, Flores RM, Robinson BE. A profile of hospitalized cocaine users: patient characteristics, diagnoses, and physician responses. Subst Abuse. 1995; 16:205-212.
21. Weathers WT, Crane MM, Sauvain KJ, Blackhurst DW. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants. Pediatrics. 1993;91:350-354.
22. Frank DA, Zuckerman BS, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988;82:888-895.
23. Galanter M, Egelko S, DeLeon G, Rohrs C, Franco H. Crack/cocaine abusers in the general hospital: assessment and initiation of care. Am J Psychiatry. 1992; 149:810-815.
24. Rivara FP, Mueller BA, Fligner CL, et al. Drug use in trauma victims. J Trauma. 1989;29:1647-1653.
25. Sloan EP, Zalenski RJ, Smith RF, et al. Toxicology screening in urban trauma patients: drug prevalence and its relationship to severity and management. J Trauma. 1989;29:1647-1653.
26. Lindenbaum GA, Carroll SF, Daskal I, Kapusnick R. Patterns of alcohol and drug abuse in an urban trauma center: the increasing role of cocaine abuse. J Trauma. 1989;29:1654-1658.
27. Jacobson AM, Hauser ST, Willett JB, et al. Psychological adjustment to IDDM: ten-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care. 1997;20:811-818.
28. Johnson DD, Palumbo PJ, Chu C. Diabetic ketoacidosis in a community based population. Mayo Clin Proc. 1980;55:83-88.
29. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic ketoacidosis: a population based study. Am J Epidemiol. 1983;117:551-558.
30. Elleman K, Soerensen N, Pederson L, et al. Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care. 1984;7:528-532.
31. Davoren PM, Bowen KM. Precipitating factors in diabetic ketoacidosis [letter]. Med J Aust. 1991;154:855-856.
32. Musey MC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans, I: cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995;18:483-489.
33. Gawin FH, Ellinwood EH Jr. Cocaine and other stimulants: actions, abuse, and treatment. N Engl J Med. 1988;318:1173-1182.
34. Christensen NJ. Norepinepnrine and epinephrine in untreated diabetics during fasting and after insulin administration. Diabetes. 1974;23:1-8.
35. Gerich JE, Karam JH, Forsham PH. Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab. 1973;37:479-481.
36. Sherline P, Lynch A, Glinsmann WH. Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology. 1972;91:680-690.
37. Exton JH, Park CR. Control of gluconeogenesis in liver, II: effects of glucagon, catecholamines and adenosine-3′,5′-monophosphate on gluconeogenesis in the perfused rat liver. J Biol Chem. 1968;243:4189-4196.
38. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol. 1978;234:E252-E256.
39. Rizza R, Haymond M, Cryer P, Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol. 1979;237:E356-E362.
40. Schade DS, Eaton RP. The regulation of plasma ketone body concentration by counter-regulatory hormones in man, III: effects of norepinepnrine in normal man. Diabetes. 1978;28:5-10.
41. Keller U, Gerber PPG, Stauffacher W. Stimulatory effect of norepinepnrine on ketogenesis in normal and insulin-deficient humans. Am J Physiol. 1984;247: E732-E739.